Canaan Inc. (CAN)
Market Cap | 267.76M |
Revenue (ttm) | 191.34M |
Net Income (ttm) | -369.18M |
Shares Out | 256.23M |
EPS (ttm) | -0.28 |
PE Ratio | n/a |
Forward PE | 2.15 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 11,568,247 |
Open | 1.200 |
Previous Close | 1.170 |
Day's Range | 1.040 - 1.290 |
52-Week Range | 0.750 - 3.500 |
Beta | 3.11 |
Analysts | Strong Buy |
Price Target | 4.25 (+304.76%) |
Earnings Date | May 17, 2024 |
About CAN
Canaan Inc. engages in the research, design, and sale of integrated circuits (IC), and lease of final mining equipment by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts; and distribution of artificial intelligence products, as well as mining business. The company has operations in the United States, Australia, Kazakhstan, Canada, Indonesia, Mainland China, Malaysia, Thailand, Cyprus, and internationally.... [Read more]
Analyst Forecast
According to 2 analysts, the average rating for CAN stock is "Strong Buy." The 12-month stock price forecast is $4.25, which is an increase of 304.76% from the latest price.
News
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ("Cana...
IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ("Cana...
Canaan Inc. Reports Unaudited First Quarter 2024 Financial Results
SINGAPORE , May 17, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial results...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ("Cana...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ("Cana...
Truveris Secures $15 Million in Series E Funding Through Canaan Partners and New Leaf Venture Partners
WILMINGTON, Del.--(BUSINESS WIRE)-- #employeebenefits--Truveris, the leader in pharmacy cost containment and program performance, today announced it has raised $15 million in Series E investment led b...
Canaan Inc. to Report First Quarter 2024 Financial Results on May 17, 2024
SINGAPORE , May 10, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its fin...
Canaan Unveils the New Avalon A1566 Mining Machines at Bitcoin Asia
SINGAPORE , May 9, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today debuted its newest product, the A1566 of t...
Canaan debuts Avalon A15 New Product Series
HONG KONG , May 9, 2024 /PRNewswire/ -- Canaan Inc. launched the star product A 1566 of Avalon A15 series, an upgraded bitcoin mining machine with Canaan's most advanced technology. Building on the p...
Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase® " or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the res...
Canaan Announces Proposed Share Purchase by Management
SINGAPORE , April 22, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that Mr. Nangeng Zhang, Chair...
Canaan Makes Statement Regarding Shelf Registration Submission
SINGAPORE , April 19, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it has filed a universal...
Canaan Shines at Blockchain Life 2024 in Dubai
DUBAI, UAE, April 18, 2024 /PRNewswire/ -- Canaan Inc. (Nasdaq: CAN), the creator of ASIC Bitcoin miners, captured the spotlight at the highly anticipated Blockchain Life 2024 event in Dubai , UAE, on...
Canaan Inc. Files 2023 Annual Report on Form 20-F
SINGAPORE , April 17, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced the filing of its annual repo...
Theralase(R) Release's 4Q2023 Interim Financial Statements
TORONTO, ON / ACCESSWIRE / March 27, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and ...
Canaan's RISC-V based edge AIoT SoC adopted VeriSilicon's ISP and GPU IPs
SHANGHAI--(BUSINESS WIRE)-- #3DNoiseReduction--VeriSilicon's ISP8000 IP is capable of real-time processing of three or more streams of high-definition video.
Canaan Inc. Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results
SINGAPORE , Feb. 27, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial result...
Canaan Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
SINGAPORE , Feb. 20, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its fi...
Theralase(R) Closes $CAN 1.2 Million Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / February 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research an...
Canaan Secures Follow-On Purchase Orders from Cipher and Stronghold
Cipher's JV entities have purchased 16,700 A1466 model Avalon Miners; the 11,000 previously bought A1346 model Avalon Miners have been delivered and installed at Cipher's Odessa Facility Stronghold ha...
Theralase Release's 3Q2023 Interim Financial Statements
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a...
Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a...
Canaan Inc. Reports Unaudited Third Quarter 2023 Financial Results
SINGAPORE , Nov. 28, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial result...
Canaan Inc. to Report Third Quarter 2023 Financial Results on November 28, 2023
SINGAPORE , Nov. 20, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its fi...
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
TORONTO, ON / ACCESSWIRE / November 17, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a...